Back to search
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Raltegravir, ATC J05AJ01
AOK Rheinland-Pfalz/Saarland - Die GesundheitskasseGermanyPublished on Jul 19, 2026
711 days left
GermanyDescription
Conclusion of non-exclusive rebate contracts in accordance with §§ 130a para. 8/130c para. 1 SGB V for medicinal products with the aforementioned active substance within the period from 01.09.2026 to 31.08.2028 with the possibility of concluding the contract at any time (open-house model). Medicinal products according to the BfArM list pursuant to § 35 para. 5a SGB V (paediatric medicinal products) are excluded from the open-house procedure.
CPV codes
Pharmaceutical products
Documents & submission
AI summary
Sign in for an AI summaryContains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Pharmaceutical products – Open-House-Originale-Rabattverträge 2026-08 Palbociclib
Techniker KrankenkasseGermanyPharmaceutical productsDeadline in 773 daysPublished on Jul 19, 2026
Germany – Medical equipments – Lieferung, Montage und Inbetriebnahme von zwei digitalen Röntgenarbeitesplätzen
Kreiskliniken Günzburg-KrumbachGermanyMedical equipmentsDeadline in 32 daysPublished on Jul 19, 2026
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Betamethason + Clotrimazol, ATC D01AC20 für die Zeit 01.09.2026 - 31.08.2028 (zzgl. V.-Option 1x12 Monate)
DAK-GesundheitGermanyPharmaceutical productsDeadline in 1,081 daysPublished on Jul 16, 2026
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Brivaracetam, ATC N03AX23 für die Zeit 01.09.2026 - 31.08.2028 (zzgl. Verlängerungsoption 1x12 Monate)
DAK-GesundheitGermanyPharmaceutical productsDeadline in 1,081 daysPublished on Jul 16, 2026